Literature DB >> 9456024

Elevated serum level of interleukin-10 in patients with systemic sclerosis.

E J Kucharz, L Brzezinska-Wcislo, A Kotulska, W Gasiorowska-Kielkowska, J Gozdzik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9456024     DOI： 10.1007/bf02247812

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  2 in total

1.  [Classification of progressive systemic scleroderma].

Authors:  H Holzmann; S Sollberg; P Altmeyer
Journal:  Hautarzt       Date:  1987-05       Impact factor: 0.751

Review 2.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527
  2 in total
  4 in total

Review 1.  Dendritic cells: novel players in fibrosis and scleroderma.

Authors:  Theresa T Lu
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

2.  Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.

Authors:  P Cipriani; P Di Benedetto; V Liakouli; B Del Papa; M Di Padova; M Di Ianni; A Marrelli; E Alesse; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

Review 3.  Immune Components of Liver Damage Associated with Connective Tissue Diseases.

Authors:  Aziz A Chentoufi; Youri A Serov; Mansour Alazmi; Kamaldeen Baba
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

Review 4.  Upcoming treatments for morphea.

Authors:  Dan Wenzel; Nazgol-Sadat Haddadi; Khashayar Afshari; Jillian M Richmond; Mehdi Rashighi
Journal:  Immun Inflamm Dis       Date:  2021-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.